CASQ1 and Malignant hyperthermia: This strategy was previously used to successfully reduce the formation of cores and susceptibility to malignant hyperthermia in mice carrying the human Y522S mutation in the RYR1 (YS mice) and in CASQ1-null mice [51,52,53].